Dysregulated tissue immunity in human fatal asthma
Rattachement africain : us. Niveau de preuve : code pays fourni par la source.
Le résumé fourni par la source
Asthma is an immune-mediated lung disease causing airway constriction that is fatal in rare cases, though the immune mechanisms underlying asthma severity are poorly understood. Here, we present a comprehensive immunological profiling of lymphoid organs, lungs, and intestines from human organ donors who died of fatal asthma (FA) compared to donors who died of unrelated causes with or without a history of asthma. Compared to control donors, FA donors exhibit elevated plasma IgE along with enhanced and aberrant immune responses in mucosal-associated lymph nodes (LN) and lungs, respectively. In particular, FA donors show increased memory T and B cells and decreased Treg cells with age in the gut- and lung-associated LN, increased Th2 and Th1 resident memory cells in the lungs, and increased associations between gut and lung immune responses compared to control donors. Our findings reveal mucosal immune dysregulation underlying asthma exacerbation through site-specific and inter-tissue disruption of immune homeostasis. Immune mechanisms driving severe asthma and fatal outcomes remain elusive. Through cross-tissue immune profiling of organ donors who died of fatal asthma versus other causes, the authors here reveal mucosal immune dysregulation marked by enhanced T- and B-cell memory, reduced Tregs, and increased lung Th2 and Th1 effectors linked to priming in gut-associated lymph nodes.
Ce résumé expose les affirmations des auteurs. BNTIC ne l’interprète pas comme une validation indépendante des résultats.
Le contrôle bibliographique ouvert
DOI retrouvé dans Crossref DOI retrouvé ; titre concordant.
- Titre Crossref
- Dysregulated tissue immunity in human fatal asthma
- Date Crossref
- 05/09/2026
- Éditeur
- Springer Science and Business Media LLC
- Type
- journal-article
Ce recoupement confirme des métadonnées liées au DOI. Il ne confirme ni la méthode ni les conclusions de l’étude, et il ne compte pas comme une seconde source scientifique indépendante.
Où se fait cette recherche
-
Columbia University Irving Medical Center Department of Microbiology and Immunology pays non établi dans la noticeÉtablissement de santé
-
Regeneron (United States) pays non établi dans la noticeEntreprise
-
Inc. Regeneron Pharmaceuticals pays non établi dans la noticeEntreprise
Department of Microbiology and Immunology — Columbia University Irving Medical Center, Regeneron (United States) et Regeneron Pharmaceuticals — Inc..
Une affiliation ne permet pas de déduire la nationalité d’un auteur.